Figure 4From: Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis Individual study and overall hazard ratios of relationships between every 4-week delay in initiation of adjuvant chemotherapy and disease-free survival. Individual and overall hazard ratios (HR) per 4-week of delay with 95% confidence interval (CI) for DFS is shown. The size of each square is proportional to the weight of the study. For the combined result, the length of the diamond represents the 95% CI of the summary.Back to article page